Jeuveau is a prescription injectable neurotoxin produced by Evolus, Inc., used primarily for cosmetic purposes to temporarily reduce the appearance of wrinkles, particularly moderate to severe glabellar lines (the frown lines between the eyebrows). Like Botox, Dysport, and Xeomin, Jeuveau contains botulinum toxin type A, which works by temporarily relaxing the muscles that cause wrinkles.
Benefits of Jeuveau
- Wrinkle Reduction: Jeuveau helps smooth out dynamic wrinkles in the face, particularly the glabellar lines. This gives the skin a more youthful, relaxed appearance.
- Fast-Acting: Patients often begin to see improvements in their skin within a few days, and full results generally appear within a week.
- Non-Surgical Option: Jeuveau is a non-invasive treatment that doesn’t require surgery or extensive downtime, making it convenient for people looking for quick cosmetic enhancements.
- Lasting Results: The effects of Jeuveau typically last between 3 to 6 months, depending on factors like muscle strength, lifestyle, and individual metabolism. Patients can maintain results with regular treatments.
- Targeted Use for Facial Symmetry: Jeuveau can be used not only to reduce wrinkles but also to enhance facial symmetry or balance specific facial features, based on the injector’s technique.
- Minimal Downtime: Unlike surgical options, there’s minimal downtime, and patients can typically resume normal activities almost immediately after the procedure.
How Jeuveau Differs from Other Neurotoxins
Jeuveau was specifically developed for cosmetic use, unlike Botox, which also has medical applications (like treating migraines and excessive sweating). Some patients find that Jeuveau provides a slightly different “feel” or result compared to other neurotoxins, though this varies by individual.
